advertisement
Journal of Ocular Pharmacology and Therapeutics 9
Showing records 1 to 9 |
Display all abstracts in Journal of Ocular Pharmacology and Therapeutics11553 Effects of the preservative puriteR on the bioavailability of brimonidine in the aqueous humor of rabbitsDong JQ; Babusis DM; Welty DF; Acheampong AA; Tang Liu D; Whitcup SM
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 285-292
11554 The comparative cardiovascular, pulmonary, ocular blood flow, and ocular hypotensive effects of topical travoprost, bimatoprost, brimonidine, and betaxololInan UU; Ermis SS; Orman A; Onrat E; Yucel A; Ozturk F; Asagidag A; Celik A
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 293-310
11575 Binding affinities of ocular hypotensive β-blockers levobetaxolol, levobunolol, and timolol at endogenous guinea pig β-adrenoceptorsSharif NA; Xu SX
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 93-99
11422 A persistency and economic analysis of latanoprost, bimatoprost, or beta-blockers in patients with open-angle glaucoma or ocular hypertensionDay DG; Schacknow PN; Sharpe ED; Ellyn JC; Kulze III JC; Threlkeld AB; Jones ED; Brown RH; Jenkins JN; Stewart WC
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 383-392
11460 Effect of different dose schedules of 0.15% unoprostone isopropyl on intraocular pressure and pupil size in the glaucomatous beagleGelatt KN; MacKay EO; Dashiell T; Biken-A
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 411-420
11424 Short-term effects of bimatoprost in glaucoma patients from an outpatient clinicIester M; Perdicchi A; Venturino G; Rolando M; Traverso CE; Leonardi E; Calabria G
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 393-400
11448 Intraocular pressure and safety in glaucoma patients switching to latanoprost/timolol maleate fixed combination from mono- and adjunctive therapiesKonstas AGP; Banyai L; Blask K-D; Vath J; Kozobolis VP; Trub PR; Tsironi S; Maloutas S; Teus MA; Stewart WC
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 375-382
11556 The efficacy and safety of once-daily versus once-weekly latanoprost treatment for increased intraocular pressureKurtz S; Shemesh G
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 321-327
11461 Intraocular pressure fluctuations in response to the water-drinking provocative test in patients using latanoprost versus unoprostoneSusanna Jr R; Medeiros FA; Vessani RM; Giampani Jr J; Borges AS; Jordao MLS
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 401-410